|

Angiotensin II Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: Giapreza (synthetic human angiotensin II)

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

  • Universität Münster1
  • University of Maryland St. Joseph Medical Center1

Indications

  • Heart Disease2
  • Vasodilatory Hypotension During or After Cardiac Surgery1
  • Cardiac Surgery1
  • Vasoplegia1

Other1 trial

Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II
Phase 3

Towson, Maryland1 trial

ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)

University of Maryland St. Joseph Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.